3Tatemoto K, Hosoya M, Habata Y, et al. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun, 1998, 20, 251: 471-476.
4Gurzu B, Petrescu BC, Costuleanu M, et al. Interactions between apelin and angiotensin lI on rat portal vein. J Renin Angiotensin Aldosterone Syst, 2006, 7: 212-216.
5Charles CJ. Putative role for apetin in pressure/volume homeostasis and cardiovascular disease. Cardiovsc Hematol Agents Med Chern, 2007.5: 1-10.
6Jia YX, Lu ZF, Zhang J, et al. Apelin activates L-arginine/nitric oxidesynthase/nitric oxide pathway in rat aortas. Peptides, 2007, 28: 2023- 2029.
7Cheng X, Cheng XS, Pang CC. Venous dilator effect of apelin, an endogenous peptide ligand for the orphan APJ receptor, in conscious rats. Eur Pharmacol, 2003, 470: 171-175.
8Lee DK, Saldivia VR, Nguyen T, et al. Modification of the terminal residue of apelin-13 antagonizes its hypotensive action. Endocrinology, 2005, 146: 231- 236.
9Salcedo A, Garijo J, Mongc L, et ah Apelin effects in human splanchnic arteries. Role of nitric and prostanoids. Regul Pept, 2007, 144: 50-55.
10Zhu P, Huang F, Lin F, et al, Plasma apelin levels, blood pressure and cardiovascular risk factors in coastal Chinese population. Ann Med, 2013, 45: 494-498.
